Literature DB >> 30266790

Dynamics and determinants of the force of infection of dengue virus from 1994 to 2015 in Managua, Nicaragua.

Leah C Katzelnick1, Rotem Ben-Shachar1,2, Juan Carlos Mercado3,4, Isabel Rodriguez-Barraquer5, Douglas Elizondo4, Sonia Arguello4, Andrea Nuñez3,4, Sergio Ojeda4, Nery Sanchez4, Brenda Lopez Mercado4, Lionel Gresh4, Raquel Burger-Calderon1,4, Guillermina Kuan6, Aubree Gordon7, Angel Balmaseda3,4, Eva Harris8.   

Abstract

Dengue virus (DENV) is the most prevalent human vector-borne viral disease. The force of infection (FoI), the rate at which susceptible individuals are infected in a population, is an important metric for infectious disease modeling. Understanding how and why the FoI of DENV changes over time is critical for developing immunization and vector control policies. We used age-stratified seroprevalence data from 12 years of the Pediatric Dengue Cohort Study in Nicaragua to estimate the annual FoI of DENV from 1994 to 2015. Seroprevalence data revealed a change in the rate at which children acquire DENV-specific immunity: in 2004, 50% of children age >4 years were seropositive, but by 2015, 50% seropositivity was reached only by age 11 years. We estimated a spike in the FoI in 1997-1998 and 1998-1999 and a gradual decline thereafter, and children age <4 years experienced a lower FoI. Two hypotheses to explain the change in the FoI were tested: (i) a transition from introduction of specific DENV serotypes to their endemic transmission and (ii) a population demographic transition due to declining birth rates and increasing life expectancy. We used mathematical models to simulate these hypotheses. We show that the initial high FoI can be explained by the introduction of DENV-3 in 1994-1998, and that the overall gradual decline in the FoI can be attributed to demographic shifts. Changes in immunity and demographics strongly impacted DENV transmission in Nicaragua. Population-level measures of transmission intensity are dynamic and thus challenging to use to guide vaccine implementation locally and globally.

Entities:  

Keywords:  Nicaragua; cohort study; dengue virus; force of infection; transmission intensity

Mesh:

Substances:

Year:  2018        PMID: 30266790      PMCID: PMC6196493          DOI: 10.1073/pnas.1809253115

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Dengvaxia sensitizes seronegatives to vaccine enhanced disease regardless of age.

Authors:  Scott B Halstead
Journal:  Vaccine       Date:  2017-10-10       Impact factor: 3.641

2.  High seroprevalence of antibodies against dengue virus in a prospective study of schoolchildren in Managua, Nicaragua.

Authors:  Angel Balmaseda; Samantha N Hammond; Yolanda Tellez; Laurel Imhoff; Yoryelin Rodriguez; Saira I Saborío; Juan C Mercado; Leonel Perez; Elsa Videa; Elvis Almanza; Guillermina Kuan; Miguel Reyes; Leyla Saenz; Juan J Amador; Eva Harris
Journal:  Trop Med Int Health       Date:  2006-06       Impact factor: 2.622

3.  [Dengue epidemic in Nicaragua, 1985].

Authors:  G Kouri; M Valdéz; L Arguello; M G Guzmán; L Valdés; M Soler; J Bravo
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1991 Sep-Oct       Impact factor: 1.846

4.  Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease.

Authors:  Sri Rezeki Hadinegoro; Jose Luis Arredondo-García; Maria Rosario Capeding; Carmen Deseda; Tawee Chotpitayasunondh; Reynaldo Dietze; H I Hj Muhammad Ismail; Humberto Reynales; Kriengsak Limkittikul; Doris Maribel Rivera-Medina; Huu Ngoc Tran; Alain Bouckenooghe; Danaya Chansinghakul; Margarita Cortés; Karen Fanouillere; Remi Forrat; Carina Frago; Sophia Gailhardou; Nicholas Jackson; Fernando Noriega; Eric Plennevaux; T Anh Wartel; Betzana Zambrano; Melanie Saville
Journal:  N Engl J Med       Date:  2015-07-27       Impact factor: 91.245

5.  Decreases in dengue transmission may act to increase the incidence of dengue hemorrhagic fever.

Authors:  Yoshiro Nagao; Katia Koelle
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-04       Impact factor: 11.205

6.  From re-emergence to hyperendemicity: the natural history of the dengue epidemic in Brazil.

Authors:  Isabel Rodriguez-Barraquer; Marli T Cordeiro; Cynthia Braga; Wayner V de Souza; Ernesto T Marques; Derek A T Cummings
Journal:  PLoS Negl Trop Dis       Date:  2011-01-04

7.  Evaluation of the traditional and revised WHO classifications of Dengue disease severity.

Authors:  Federico Narvaez; Gamaliel Gutierrez; Maria Angeles Pérez; Douglas Elizondo; Andrea Nuñez; Angel Balmaseda; Eva Harris
Journal:  PLoS Negl Trop Dis       Date:  2011-11-08

8.  Estimating dengue transmission intensity from sero-prevalence surveys in multiple countries.

Authors:  Natsuko Imai; Ilaria Dorigatti; Simon Cauchemez; Neil M Ferguson
Journal:  PLoS Negl Trop Dis       Date:  2015-04-16

9.  Estimating Dengue Transmission Intensity from Case-Notification Data from Multiple Countries.

Authors:  Natsuko Imai; Ilaria Dorigatti; Simon Cauchemez; Neil M Ferguson
Journal:  PLoS Negl Trop Dis       Date:  2016-07-11

10.  The Nicaraguan pediatric dengue cohort study: study design, methods, use of information technology, and extension to other infectious diseases.

Authors:  Guillermina Kuan; Aubree Gordon; William Avilés; Oscar Ortega; Samantha N Hammond; Douglas Elizondo; Andrea Nuñez; Josefina Coloma; Angel Balmaseda; Eva Harris
Journal:  Am J Epidemiol       Date:  2009-05-12       Impact factor: 4.897

View more
  13 in total

1.  Antibody-Dependent Enhancement of Severe Disease Is Mediated by Serum Viral Load in Pediatric Dengue Virus Infections.

Authors:  Jesse J Waggoner; Leah C Katzelnick; Raquel Burger-Calderon; Julia Gallini; Renee H Moore; Guillermina Kuan; Angel Balmaseda; Benjamin A Pinsky; Eva Harris
Journal:  J Infect Dis       Date:  2020-05-11       Impact factor: 5.226

Review 2.  Projecting the SARS-CoV-2 transition from pandemicity to endemicity: Epidemiological and immunological considerations.

Authors:  Lily E Cohen; David J Spiro; Cecile Viboud
Journal:  PLoS Pathog       Date:  2022-06-30       Impact factor: 7.464

3.  Assessing the role of multiple mechanisms increasing the age of dengue cases in Thailand.

Authors:  Angkana T Huang; Saki Takahashi; Henrik Salje; Lin Wang; Bernardo Garcia-Carreras; Kathryn Anderson; Timothy Endy; Stephen Thomas; Alan L Rothman; Chonticha Klungthong; Anthony R Jones; Stefan Fernandez; Sopon Iamsirithaworn; Pawinee Doung-Ngern; Isabel Rodriguez-Barraquer; Derek A T Cummings
Journal:  Proc Natl Acad Sci U S A       Date:  2022-05-09       Impact factor: 12.779

4.  Zika virus infection enhances future risk of severe dengue disease.

Authors:  Leah C Katzelnick; César Narvaez; Sonia Arguello; Brenda Lopez Mercado; Damaris Collado; Oscarlett Ampie; Douglas Elizondo; Tatiana Miranda; Fausto Bustos Carillo; Juan Carlos Mercado; Krista Latta; Amy Schiller; Bruno Segovia-Chumbez; Sergio Ojeda; Nery Sanchez; Miguel Plazaola; Josefina Coloma; M Elizabeth Halloran; Lakshmanane Premkumar; Aubree Gordon; Federico Narvaez; Aravinda M de Silva; Guillermina Kuan; Angel Balmaseda; Eva Harris
Journal:  Science       Date:  2020-08-28       Impact factor: 47.728

5.  Opportunities for improved surveillance and control of dengue from age-specific case data.

Authors:  Isabel Rodriguez-Barraquer; Henrik Salje; Derek A Cummings
Journal:  Elife       Date:  2019-05-23       Impact factor: 8.713

6.  Enteropathogen antibody dynamics and force of infection among children in low-resource settings.

Authors:  Benjamin F Arnold; Diana L Martin; Jane Juma; Harran Mkocha; John B Ochieng; Gretchen M Cooley; Richard Omore; E Brook Goodhew; Jamae F Morris; Veronica Costantini; Jan Vinjé; Patrick J Lammie; Jeffrey W Priest
Journal:  Elife       Date:  2019-08-19       Impact factor: 8.140

7.  Impact of pre-existing dengue immunity on human antibody and memory B cell responses to Zika.

Authors:  Paulina Andrade; Ciara Gimblet-Ochieng; Faraz Modirian; Matthew Collins; Maritza Cárdenas; Leah C Katzelnick; Magelda Montoya; Daniela Michlmayr; Guillermina Kuan; Angel Balmaseda; Josefina Coloma; Aravinda M de Silva; Eva Harris
Journal:  Nat Commun       Date:  2019-02-26       Impact factor: 14.919

8.  Serological inference of past primary and secondary dengue infection: implications for vaccination.

Authors:  Ha Minh Lam; Huynh Thi Phuong; Nguyen Ha Thao Vy; Nguyen Thi Le Thanh; Pham Ngoc Dung; Thai Thi Ngoc Muon; Nguyen Van Vinh Chau; Isabel Rodríguez-Barraquer; Derek A T Cummings; Bridget A Wills; Maciej F Boni; Maia A Rabaa; Hannah E Clapham
Journal:  J R Soc Interface       Date:  2019-07-31       Impact factor: 4.118

9.  Designing effective control of dengue with combined interventions.

Authors:  Thomas J Hladish; Carl A B Pearson; Kok Ben Toh; Diana Patricia Rojas; Pablo Manrique-Saide; Gonzalo M Vazquez-Prokopec; M Elizabeth Halloran; Ira M Longini
Journal:  Proc Natl Acad Sci U S A       Date:  2020-01-23       Impact factor: 11.205

10.  Fine-scale heterogeneity in Schistosoma mansoni force of infection measured through antibody response.

Authors:  Benjamin F Arnold; Henry Kanyi; Sammy M Njenga; Fredrick O Rawago; Jeffrey W Priest; W Evan Secor; Patrick J Lammie; Kimberly Y Won; Maurice R Odiere
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-31       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.